Dr. Bodo Brückner
After his studies of Biology at the University of Heidelberg, Bodo Brückner was awarded his doctorate at the Center of Molecular Biology (ZMBH) in the laboratory of Renato Paro in Heidelberg.
He then started postdoc positions at the Instituto de Parasitología y Biomedicina "López-Neyra" in Granada (Spain) and at the German Cancer Research Center (DKFZ).
At the DKFZ he worked with Prof. Frank Lyko on cancer epigenetics and was involved in several translational research projects with Cancer Research United Kingdom, Clavis Pharma ASA, Bayer HealthCare and Beiersdorf AG.
Since January 2011 he has been working as a freelancing/self-employed consultant scientist.
From August 2011 to March 2015, Bodo Brückner enhanced the BioRN Clustermanagement as an innovation manager in the department of project and science management. To foster life science entrepreneurship and the creation of start-ups, Dr. Brückner teaches Master and PhD students at the Biotech Entrepreneurship Training Program at Heidelberg University.
Since April 2015, Bodo Brückner has been working as an Entrepreneurship Manager at German EIT Health GmbH where he is responsible for education activities, with a focus on entrepreneurship. He is also member of the EIT Health Education Committee and leads the MOOC and Digital Engagement segment in EIT Health Campus.
Eva-Maria Gottmann is a marketing and communication specialist, connecting communication and design skills with entrepreneurship.
Eva studied Media and Communication Sciences at the universities of Erfurt, Augsburg, and Barcelona. During her stay in Catalonia’s capital she decided to turn her theoretical knowledge into practice. Thus she began working as a freelance journalist while finishing her master’s thesis.
In 2013 she joined the BioRN Cluster Management as online editor. Since then she has been involved in the Biotech Entrepreneurship activities at Heidelberg University and further business creation programs such as the "Health Axis Europe Accelerator" for start-ups. Furthermore, Eva created and implemented a communication and marketing strategy for the BioMed X Innovation Center.
Since July 2016 she is Business Creation Manager at German EIT Health providing accelerator and education services to EIT Health members and start-ups in the field of biotech, medtech and digital health.
Dr. Christian Tidona
Christian Tidona is a serial biotech entrepreneur and managing director at the BioMed X Innovation Center and BioRN Network in Heidelberg, Germany.
He studied biology and received his PhD at the University of Heidelberg. After ten years of experience in startup and leadership of biotech companies such as Multimetrix in Regensburg, Cytonet near Heidelberg, and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), he was instrumental in the development and implementation of a new economic growth strategy for the Biotech Cluster Rhine-Neckar (BioRN). Based on this strategy the BioRN cluster, which is centered around the biomedical campus of the University of Heidelberg, was distinguished as one of the five strongest high-tech regions in Germany (Leading Edge Cluster Competition). It was awarded a 40 million Euro grant from the Federal Ministry for Education and Research (BMBF) which is now being used under Christian's leadership together with another 40 million Euro from the local pharma and biotech industry for the implementation of the new growth strategy.
He is coordinator of the pan-European TiE International Business Plan Competition in collaboration with TiE Global in Santa Clara, California and the Rice Alliance in Houston, Texas. He is member of the Responsible Leaders Impact Circle for Social Innovations of the BMW Foundation Herbert Quandt, and teaching entrepreneurship at the University of Heidelberg. Christian also serves on the executive board of the Health Axis Europe alliance between the European health innovation clusters in Cambridge, Leuven and Heidelberg.
After her bachelor studies in Biology at the Eberhard Karls University in Tübingen, Selina got enrolled in the Molecular Biotechnology Master Program of the University of Heidelberg with a focus on drug development. Currently, she is concluding her master studies with a thesis at the Institute for Pharmacy and Molecular Biotechnology (IPMB) in the research group of Prof. Dr. Gert Fricker in Heidelberg.
At the IPMB, Selina is investigating the interactions of potential drug candidates with the ATP-binding cassette (ABC) transporter breast cancer resistance protein (BCRP), which plays an important role in drug absorbance and elimination.
Yet, Selina is interested in more than just purely science. During her master studies she participated in the Biotech Entrepreneurship Training Program (BETP). She did not only learn about how to gain VC investments for a startup company, but also how fascinating the entrepreneurial journey can be when trying to transform creative ideas into innovative products. As a consequence, Selina decided to join the team.
Just recently, Selina also participated in a hackathon and shared her impressions live via twitter (@shutzl).